1.
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation
by Saharinen, Pipsa
Trends in immunology, 2004, Vol.25 (7), p.387-395
2.
Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Functions to Promote Uterine Decidual Angiogenesis during Early Pregnancy in the Mouse
by Douglas, Nataki C
Endocrinology (Philadelphia), 2009, Vol.150 (8), p.3845-3854
3.
Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cells
by Wu, Chia-Ching
Journal of biomechanics, 2007, Vol.41 (4), p.813-821
4.
Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism
by Machnik, A
Nature medicine, 2009, Vol.15 (5), p.545-552
5.
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth
by Dridi, Sami
Nature medicine, 2009, Vol.15 (9), p.1023-1030
6.
Adverse effects of anticancer agents that target the VEGF pathway
by Chen, Helen X
Nature reviews. Clinical oncology, 2009, Vol.6 (8), p.465-477
7.
Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by Apatinib
by Peng, Sui
Cancer letters, 2016, Vol.373 (2), p.193-202
8.
Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
by Bremnes, Roy M
Lung cancer (Amsterdam, Netherlands), 2006, Vol.51 (2), p.143-158
9.
Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
by Facemire, Carie S
Hypertension (Dallas, Tex. 1979), 2009, Vol.54 (3), p.652-658
10.
VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis
by Kuo, Calvin J
Nature medicine, 2006, Vol.12 (7), p.793-800
11.
The lymphatic vasculature: recent progress and paradigms
by Oliver, Guillermo
Annual review of cell and developmental biology, 2005, Vol.21 (1), p.457-483
12.
Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs—syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin’s lymphoma...
by Gharbaran, Rajendra
Tumor biology, 2016, Vol.37 (9), p.11573-11588
13.
Novel angiogenic signaling pathways and vascular targets
by BICKNELL, Roy
Annual review of pharmacology and toxicology, 2004, Vol.44 (1), p.219-238
14.
New Approaches for Managing Preeclampsia: Clues From Clinical and Basic Research
by George, Eric M., PhD
Clinical therapeutics, 2014, Vol.36 (12), p.1873-1881
15.
Cigarette Smoke–induced Oxidative/Nitrosative Stress Impairs VEGF- and Fluid Shear Stress–Mediated Signaling in Endothelial Cells
by Edirisinghe, Indika
Antioxidants & redox signaling, 2010, Vol.12 (12), p.1355-1369
16.
Vascular-specific growth factors and blood vessel formation
by Yancopoulos, George D
Nature (London), 2000, Vol.407 (6801), p.242-248
17.
Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell
by Huan-huan, Chen
Cancer letters, 2004, Vol.211 (2), p.163-173
18.
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
by Ferrara, Napoleone
Nature medicine, 1999, Vol.5 (6), p.623-628
19.
Vascular Endothelial Growth Factor and Its Receptor, Flk-1/KDR, Are Cytoprotective in the Extravascular Compartment of the Ovarian Follicle
by Greenaway, James
Endocrinology (Philadelphia), 2004, Vol.145 (6), p.2896-2905
20.
Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients
by Zhao, Ying-Chun
Medical oncology (Northwood, London, England), 2012, Vol.29 (4), p.2594-2600
